JP2017014206A5 - - Google Patents

Download PDF

Info

Publication number
JP2017014206A5
JP2017014206A5 JP2016128584A JP2016128584A JP2017014206A5 JP 2017014206 A5 JP2017014206 A5 JP 2017014206A5 JP 2016128584 A JP2016128584 A JP 2016128584A JP 2016128584 A JP2016128584 A JP 2016128584A JP 2017014206 A5 JP2017014206 A5 JP 2017014206A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
day
patient
months
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016128584A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017014206A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017014206A publication Critical patent/JP2017014206A/ja
Publication of JP2017014206A5 publication Critical patent/JP2017014206A5/ja
Pending legal-status Critical Current

Links

JP2016128584A 2015-06-30 2016-06-29 腹水の治療 Pending JP2017014206A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201562186638P 2015-06-30 2015-06-30
US62/186,638 2015-06-30
US201562267510P 2015-12-15 2015-12-15
US62/267,510 2015-12-15
US201662321558P 2016-04-12 2016-04-12
US62/321,558 2016-04-12

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018145654A Division JP2018172440A (ja) 2015-06-30 2018-08-02 腹水の治療

Publications (2)

Publication Number Publication Date
JP2017014206A JP2017014206A (ja) 2017-01-19
JP2017014206A5 true JP2017014206A5 (OSRAM) 2017-08-31

Family

ID=57609113

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2016128584A Pending JP2017014206A (ja) 2015-06-30 2016-06-29 腹水の治療
JP2018145654A Pending JP2018172440A (ja) 2015-06-30 2018-08-02 腹水の治療
JP2020115254A Pending JP2020172520A (ja) 2015-06-30 2020-07-03 腹水の治療
JP2022107055A Pending JP2022136104A (ja) 2015-06-30 2022-07-01 腹水の治療
JP2023133333A Pending JP2023160839A (ja) 2015-06-30 2023-08-18 腹水の治療
JP2025107051A Pending JP2025143324A (ja) 2015-06-30 2025-06-25 腹水の治療

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2018145654A Pending JP2018172440A (ja) 2015-06-30 2018-08-02 腹水の治療
JP2020115254A Pending JP2020172520A (ja) 2015-06-30 2020-07-03 腹水の治療
JP2022107055A Pending JP2022136104A (ja) 2015-06-30 2022-07-01 腹水の治療
JP2023133333A Pending JP2023160839A (ja) 2015-06-30 2023-08-18 腹水の治療
JP2025107051A Pending JP2025143324A (ja) 2015-06-30 2025-06-25 腹水の治療

Country Status (7)

Country Link
US (6) US9655945B2 (OSRAM)
EP (2) EP3347032B1 (OSRAM)
JP (6) JP2017014206A (OSRAM)
CN (2) CN120324576A (OSRAM)
ES (1) ES2971959T3 (OSRAM)
HK (1) HK1258611A1 (OSRAM)
WO (1) WO2017004317A1 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20170929T1 (hr) 2008-09-17 2017-09-22 Chiasma Inc. Farmaceutski pripravci i odgovarajući postupci za isporuku
JP6673915B2 (ja) 2014-10-24 2020-03-25 マリンクロット ホスピタル プロダクツ アイピー リミテッド １型肝腎症候群患者の治療方法
AU2016215350B2 (en) 2015-02-03 2021-11-25 Amryt Endo, Inc. Method of treating diseases
JP2017014206A (ja) * 2015-06-30 2017-01-19 ナノアンティバイオティクス，インコーポレイテッド 腹水の治療
EP3528828B1 (en) 2016-10-21 2025-01-29 Amryt Endo, Inc. Terlipressin composition for use in treating ascites
CN112704727B (zh) * 2021-01-12 2023-05-16 重庆医科大学附属第二医院 特利加压素在制备动力性肠梗阻药物中的应用
CN113077888A (zh) * 2021-03-30 2021-07-06 福州宜星大数据产业投资有限公司 自动化meld评分方法、终端及存储介质
WO2023150254A1 (en) * 2022-02-03 2023-08-10 Biovie Inc. Methods of treating disease with terlipressin

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1188443A1 (en) * 2000-09-15 2002-03-20 Ferring BV Improved protocol for paracentesis
US8222202B2 (en) * 2006-02-13 2012-07-17 Ferring B.V. Use of peptidic vasopressin receptor agonists
US9050286B2 (en) * 2007-08-14 2015-06-09 Ferring B.V. Use of peptidic vasopression receptor agonists
EP2203172A2 (en) * 2007-09-28 2010-07-07 Ferring B.V. Use of v2 receptor antagonists in combination with vasopressinergic agonists
US20110003890A1 (en) * 2007-11-08 2011-01-06 Jason Joel Schwartz Use of angiogenesis antagonists in conditions of abnormal venous proliferation
WO2010023195A2 (en) * 2008-08-26 2010-03-04 Kyon Biotech Ag Compositions and methods for treating cancer
ES2661310T3 (es) * 2009-03-09 2018-03-28 Bioatla, Llc Proteínas mirac
AU2010258888B2 (en) * 2009-06-08 2014-08-07 Ocera Therapeutics, Inc. Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate
AU2011279144A1 (en) * 2010-07-14 2013-01-24 Cumberland Emerging Technologies, Inc Methods of treating hepatorenal syndrome and hepatic encephalopathy with thromboxane-A2 receptor antagonists
WO2013106072A1 (en) * 2012-01-10 2013-07-18 Sorbent Therapeutics, Inc. Compositions comprising crosslinked cation-binding polymers and uses thereof
JO3109B1 (ar) * 2012-05-10 2017-09-20 Ferring Bv منبهات لمستقبلات v1a
CN102731625B (zh) * 2012-06-27 2014-10-15 深圳翰宇药业股份有限公司 一种纯化特利加压素的方法
CA3191764A1 (en) * 2012-11-12 2014-05-15 The Regents Of The University Of Colorado, A Body Corporate Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis
EP2988770A4 (en) * 2013-04-26 2016-12-14 La Jolla Pharma Co COMPOSITIONS AND METHOD FOR TREATING KIDNEY FAILURES
US20150056194A1 (en) * 2013-08-21 2015-02-26 Georgia Regents Research Institute, Inc. Modified green tea polyphenols and methods thereof for treating liver disease
JP2017014206A (ja) * 2015-06-30 2017-01-19 ナノアンティバイオティクス，インコーポレイテッド 腹水の治療

Similar Documents

Publication Publication Date Title
JP2017014206A5 (OSRAM)
JP2018172440A5 (OSRAM)
JP2015083580A5 (OSRAM)
JP2016034978A5 (OSRAM)
JP2017537066A5 (OSRAM)
JP2013509429A5 (OSRAM)
EA201401028A1 (ru) Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害（ａｄｈｄ）の治療方法
JP2012512907A5 (OSRAM)
JP2012515184A5 (OSRAM)
IL292465B2 (en) Neuroactive compounds and methods of use thereof
JP2017500289A5 (OSRAM)
JP2015516419A5 (OSRAM)
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
JP2020097577A5 (OSRAM)
JP2013166781A5 (OSRAM)
JP2018513188A5 (OSRAM)
JP2016510326A5 (OSRAM)
JP2019529541A5 (OSRAM)
JP2017508817A5 (OSRAM)
JP2018509419A5 (OSRAM)
JP2018503644A5 (OSRAM)
JP2015522603A5 (OSRAM)
JP2019518022A5 (OSRAM)
JP2015507020A5 (OSRAM)